1 / 2

Mar 12

2012 Marketplace Timeline for Generic Drugs. SEROQUEL bipolar/ schizophrenia. CLARINEX allergies. LEXAPRO depression. SINGULAIR allergies. AVANDIA diabetes. DIOVAN blood pressure. AVAPRO/ AVALIDE blood pressure. TRICOR High triglycerides. REVATIO pulmonary HTN. PROVIGIL

bona
Download Presentation

Mar 12

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. 2012 Marketplace Timeline for Generic Drugs SEROQUEL bipolar/ schizophrenia CLARINEX allergies LEXAPRO depression SINGULAIR allergies AVANDIA diabetes DIOVAN blood pressure AVAPRO/ AVALIDE blood pressure TRICOR High triglycerides REVATIO pulmonary HTN PROVIGIL narcolepsy ATACAND blood pressure ACTOS diabetes Feb 12 Mar 12 Mar 12 Mar 12 Mar 12 Apr 12 May 12 Jul 12 Aug 12 Aug 12 Sept 12 Dec12 GEODON bipolar/ schizophrenia VIAGRA erectile dysfunction PLAVIX anti-platelet Generic Exclusivity Expected Expect 10-20% price reduction Expected Launch Possible Launch Multiple Generic Manufacturers Expect 50-80% price reduction

  2. 2013 Marketplace Timeline for Generic Drugs RECLAST/ ZOMETA Osteoporosis/Cancer CYMBALTA Depression/Pain ZOMIG Migraine ACIPHEX GI NIASPAN Triglycerides VALCYTE Anti-viral PROPECIA Baldness Jan 13 Mar 13 Mar 13 Apr 13 May 13 Sept 13 Nov. 13 Dec13 OXYCONTIN Pain LUNESTA Insomnia Generic Exclusivity Expected Expect 10-20% price reduction Expected Launch Possible Launch Multiple Generic Manufacturers Expect 50-80% price reduction

More Related